Aichi Cancer Center ( Site 0803)

Nagoya, Aichi-ken 464-8681

0 studies enrolling now · 1 studies all time

What they study most

Carcinoma, Nonsquamous Non-small-cell Lung

Studies at this site

• Study of Pembrolizumab With Maintenance Olaparib or Maintenance Pemetrexed in First-line (1L) Metastatic Nonsquamous Non-Small-Cell Lung Cancer (NSCLC) (MK-7339-006, KEYLYNK-006) — Completed